Member Info for CHELSEA7

Buys 82k

Sells 50k

Nice one inan, just thinking of buying a couple of grands worth myself.

bobust, its a possibility, like most things are, without any facts from Scancell, which in so many cases would stop the endless speculation we have to sift through.

Isleworth Spy, you posted..................................IsleworthSpy
Posts: 602
Opinion: No Opinion
Price: 0.775
RE: Gilders01Wed 19:03@ Chelsea7
It would now appear that you are an oncology expert.

So in your expert opinion, how long does it take to bring these compounds to the market?
From inception to actual human use.

I Spy.

Isleworth Spy, where did i come over as an oncology expert?? It was just one example of how little progress has been made taking into account all the raisings that have taken place.

What I would say is that ten years from preception to Approval in Phase 3 is not uncommon, and save for your sarcastic remark I believe that attending UCLH just about every week for seven years for treatments to my own lung cancer, the progress of other companies, yes gives me more knowledge than just an AIM punter, but an expert.....no!!!

Gilders was unavailable yesterday, will post up the others over the weekend.

18/01/2019 09:44 52,525 8.1
18/01/2019 08:38 5,000 8.1

Buys or Sells?

Morning, I would have thought unlikely as the government shutdown has only been a recent issue, but if resubmitting for IND took place, who knows it might have got caught up. Anyway is the trial taking place completely outside of America?

Morning, evening and soon to goodnight. Good finds. It is what it is, we have a good chance of winning this, Ray and crumbs particularly have given good reasons why, and yes to a degree it is a diversion in as much our next target has been GC. Looking beyond it will be amazing to win, not a disaster to lose, there is a lot more commercially on the table in either circumstance. A growing reputation is built over a series of time, this is just another step in the right direction.

Noticed a few negative posts reading up from this morning, even down to raising expectations we have been careful not to do that, the opportunity to win this is Scancells, not our, and the amazing team Blueprint that Lindy has helped build. An exciting week in store for sure.

Night guys, lets see this as a step forward with more relationships created for ongoing collaborations, I am.

Absolutely and you know what they say its not about what you know, although that is a lot but who you know, and with their help more and more contacts are being forged.

We can only imagine the due diligance that had taken place on Scancell of late,so fair to say our criteria as a responsible partner is not in question, and with the added advantage of Lindy Durrant as our (CSO) the appeal of Scancell becomes ever clearer, at a time when funding has never been more in this fight against cancer. Another updated forecast from CRUK as to three out of four people surviving cancer now for ten years by year 2034. Targets which are changing up regularly. Seems the basis for our confidence has firm foundations and not just blind hope a lot more substantive than that.

I"m rather proud of the relationship we have developed with CRUK, ..............................

Encouraging entrepreneurialism and internationalisation

Going forward, the organisation plans to expand its international footprint in cancer research and move towards a more global outlook. This is reflected in its Grand Challenge scheme, which provides up to £20 million of funding for international, multidisciplinary teams harnessing novel methods to take on the biggest challenges in cancer research. The 2017-2018 Grand Challenges span: tissue specificity; tumour vaccinology; treatment regimens; dormancy; lethal vs non-lethal; artificial intelligence; microbiota; cancer causes. “This is a good example of where we are addressing the big unmet need questions in oncology on an international playing field, and bringing the right people together to get those questions answered,” says Masterson.

The organisation is also ramping up efforts to assist researchers in better understanding the routes and funding options available for moving their ideas from the lab towards the market. “We will be doing a lot more around enterprise education and stimulating entrepreneurship, particularly at CRUK institutes and academic partners, and [we will be] working closely with our academic university partners to do that,” says Hickson. To launch these activities, in November 2018 CRUK hosted its first Innovation Summit. The event featured a range of panel and speaker sessions, workshops, networking and Q&A opportunities centred on fostering entrepreneurialism in oncology.

These new initiatives, alongside the existing frameworks through which the Commercial Partnerships team engages with industry, are both underpinned by and designed to realise the charity’s aim of accelerating progress in cancer research. As Hickson notes: “We want to position ourselves as a partner of choice for oncology translation and commercialisation, and help Cancer Research UK and patients achieve the overall objective of three out of four patients enjoying 10-year survival by 2034.”

Night guys

Gilders, found this one from 4th October, might sound a bit out of place posted in isolation, but the others, the bigger ones that took a week11 won"t be too far before. Just making a point about actual progress in this one. Goodnight..................

VALRE: Fourteen4 Oct '18
Now that is from VAL RNSs. And £££££m raised during that time. Six and a half years on? FACTVALFourteen4 Oct '18
Well you told me amongst the insults I wasn"t researched!!! Part One 101...............................

VAL 101 – 15/12/2011 Val said ‘..production of the VAL101 compound is going to plan and has been optimised and simplified, which by extension makes the compound cheaper to produce, thereby adding future value. ... VAL101 progressing well in preclinical development.’
Nearly 6 and a half years later on 19/4/18 they said ‘..the successful optimisation of the VAL101 molecule. This will be the compound that will be taken forward for preparation and use in clinical trials.’
So Val 101 – pushing seven years and....zilch. Who would be in discussions about that?

Just an example of the RNSs you swear by. Make your own minds up?

Buys 74k

Sells 291k

Last two sells at 8p, last buy 8.25

AT 8.10 from 13.30.

Does anybody really believe these are PI sells? But the MMs are happy to soak them up, still 3 MMs on 8p bid and time for more trades.

Will have a look for them Gilders by tomorrow, would be inerested in your opinion, not one person gave theirs and it wasn"t my opinion it was factually information taken from 7/8 years of RNSs.

And still comments like i am not researched on VAL are made because i am not invested. Well maybe it is because i have been researching VAL for years that is why i am not invested, and the reason nobody debates the science perhaps is they haven"t got a clue.

BTW, it is far from just VAL and SCLP I keep tabs on, the whole Biotech sector fascinates me, particularly those in the cancer and respiratory sectors. Simply they are both areas that affect me directly and the posts i receive saying how can i not support VAL with having lung cancer are totally irrelevant. One of the issues i have here is how little money against what has been raised has been used on patients in trials. According to the rampers VAL are prepsring for Phase 3 trials, that IMO is not even worthy to post, they have more patients to trial in different cohorts, so nowhere near Phase 3. It is a sad fact of life that small Bios are totally reliant on outside funding until commercial deals bring in an income. I think the fall from 7p highlights only too well that.

Of course i want to see great results in the lung cancer sector, regardless of who they come from, in fact nothing pleases me more to see positive data from all conditions, and to suggest as many have I want to see VAL fail is scandalous, I think rather VAL are doing a blinding job of doing that themselves. It would sure be a good thing to take part in hearty debate, rather than see paid derampers and trolls used in every post!!!!!

And BioNTech have had a couple of years to look at Moditpe from a privilaged position, applicable to all in team Blueprint. Must say it has taken me a long time to fully understand boomorbusts interest in the antigens used. Good link

Yeah noticed that Monday inan. Any relevance particularly?

For 19k, going back up.

They were all posted in the last couple of months, sorry i havent kept them. Shouldn"t take too long to find i haven"t been posting that much of late. Maybe try November backwards.

You will see as accused, it is a nonsense i spend all my time on VAL, you might even care to read my other posts where i have no problem posting on issues which could be sensitive. The beauty of accomadating a BB where there are two opinions, if not more, is it allows questions you do have to be debated which either way have an effect on your understanding of your investment,

Sorry to be repetitive but too many posts here over time have been just hopes rather than facts as they are claimed to be.

Boogles yeah we all do, I just think that those that do by large have pretty big holdings, others playing the market with their trading pots, This is a very interesting time for sure, lets all hope that breakthrough news comes soon, and IMHO there are a few items of inflection driven news that we can get over H1.

FTSEBUYER, indeed lets hope so. Considering the level of sells the last couple of months, we seem at least to be holding 8p as a base, there really aren"t many/if any Bios on AIM with a pipeline like ours. Verona, who sadly failed a Phase2 trial for COPD (everybody does), IMM and others were all binary plays really, we just need a big breakthrough which will serve as a stable funding base and further commercial deals.

I rather fancy in our CRUK team we have the necessary players to achieve that. GL

Reasonable question, and TBH one i have answered a few times very honestly and as a result been subject to shocking personal abuse.

I think you have seen just some of the abuse so no point going there again, but for ease of conversation and out of respect it is my opinion that the posts made here bear no reality to the true position of Valirax, and as a result many PIs have lost large amounts of money.

When i do challenge somebody to back up a post i get abused, recently i did a revoew of all Vals pipeline from RNSs which in return produced an avlanche of ""i am filtered". Staggering responses.

I would welcome a time to explain it further, but i trust you get it so far. ATB

Buys 27k

Sells 83k

Last trade 82,222 sell 8.123, 3 MMs still on 8p